Ines Beyer
Impact in
Papers in ⓘ
-
- RNA Interference and Gene Delivery 3
- Oncology 10
- CAR-T cell therapy research 4
- Cancer Cells and Metastasis 3
- Co-authors
- André Lieber (11 shared papers)Robert Strauss (3 shared papers)Charles W. Drescher (4 shared papers)Akseli Hemminki (4 shared papers)Nicole Urban (3 shared papers)Jonas Persson (5 shared papers)Thomas Möller (2 shared papers)Zongyi Li (5 shared papers)
- Journals
- PLoS ONE (3 papers)Archives of Gynecology and Obstetrics (3 papers)Molecular Therapy (2 papers)Fertility and Sterility (2 papers)Clinical Cancer Research (1 paper)
- Partner nations
- GermanyUnited StatesTaiwan
In The Last Decade
Ines Beyer
32 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 96
- Oncology 458
- Genetics 402
- Reproductive Medicine 121
- Obstetrics and Gynecology 87
- Immunology 212
Countries citing papers authored by Ines Beyer
This map shows the geographic impact of Ines Beyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ines Beyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ines Beyer more than expected).
Fields of papers citing papers by Ines Beyer
This network shows the impact of papers produced by Ines Beyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ines Beyer. The network helps show where Ines Beyer may publish in the future.
Co-authors
The 25 scholars most cited alongside Ines Beyer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 328 | |
| 2 | 2011 | 161 | |
| 3 | 2011 | 69 | |
| 4 | 2010 | 61 | |
| 5 | 2017 | 56 | |
| 6 | 2012 | 53 | |
| 7 | 2012 | 46 | |
| 8 | 2009 | 42 | |
| 9 | 2011 | 36 | |
| 10 | 2012 | 35 | |
| 11 | 2014 | 35 | |
| 12 | 2021 | 34 | |
| 13 | 2021 | 29 | |
| 14 | 2009 | 26 | |
| 15 | 2003 | 25 | |
| 16 | 2011 | 24 | |
| 17 | 2013 | 22 | |
| 18 | Cysteine-rich fibroblast growth factor receptor 1, a new marker for precancerous epithelial lesions defined by the human monoclonal antibody PAM-1. | 2003 | 22 |
| 19 | 2010 | 22 | |
| 20 | 2012 | 20 |
About Ines Beyer
Ines Beyer is a scholar working on Molecular Biology, Oncology, Immunology, Reproductive Medicine and Genetics, having authored 32 papers that have together received 1.2k indexed citations. Recurring topics across this work include Virus-based gene therapy research (7 papers), Endometriosis Research and Treatment (7 papers), Immunotherapy and Immune Responses (4 papers), CAR-T cell therapy research (4 papers), Endometrial and Cervical Cancer Treatments (3 papers), Cancer Cells and Metastasis (3 papers), RNA Interference and Gene Delivery (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). The work is most often cited by research in Oncology (458 citations), Genetics (402 citations), Reproductive Medicine (121 citations), Obstetrics and Gynecology (87 citations) and Immunology (212 citations). Ines Beyer has collaborated with scholars based in Germany, United States and Taiwan. Frequent co-authors include André Lieber, Robert Strauss, Charles W. Drescher, Akseli Hemminki, Nicole Urban, Jonas Persson, Thomas Möller, Zongyi Li, Xiao‐Bing Zhang and Ruan van Rensburg. Their work appears in journals such as PLoS ONE, Archives of Gynecology and Obstetrics, Molecular Therapy, Fertility and Sterility and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.